Share Name Share Symbol Market Type Share ISIN Share Description
Schroder Uk Public Private Trust Plc LSE:SUPP London Ordinary Share GB00BVG1CF25 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.00 -2.99% 32.50 923,566 16:35:10
Bid Price Offer Price High Price Low Price Open Price
32.00 33.00 32.65 32.65 32.65
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments -5.07 -0.56 295
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:10 UT 12,838 32.50 GBX

Schroder Uk Public Private (SUPP) Latest News

More Schroder Uk Public Private News
Schroder Uk Public Private Investors    Schroder Uk Public Private Takeover Rumours

Schroder Uk Public Private (SUPP) Discussions and Chat

Schroder Uk Public Private Forums and Chat

Date Time Title Posts
21/9/202114:11::: SCHRODER UK PUBLIC PRIVATE TRUST :::997
13/7/202114:33Schroder UK Public Private 289
18/2/200409:0824 Hour clock1

Add a New Thread

Schroder Uk Public Private (SUPP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Schroder Uk Public Private trades in real-time

Schroder Uk Public Private (SUPP) Top Chat Posts

Schroder Uk Public Private Daily Update: Schroder Uk Public Private Trust Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker SUPP. The last closing price for Schroder Uk Public Private was 33.50p.
Schroder Uk Public Private Trust Plc has a 4 week average price of 31p and a 12 week average price of 29.30p.
The 1 year high share price is 39.85p while the 1 year low share price is currently 25.05p.
There are currently 908,639,238 shares in issue and the average daily traded volume is 1,194,637 shares. The market capitalisation of Schroder Uk Public Private Trust Plc is £295,307,752.35.
kooba: Think this announcement is clearly value sensitive to SUPPs largest holding and they don't put anything out..they reacted last time after the share price moved. I rather think the idea is to be able to predict sensitivity and announce accordingly to all shareholders. Not the best...but great news it seems.
spectoacc: Oxford Nano float news was out earlier today - haven't read it in depth. Worth a comparison btwn IPO share price & SUPP s/p, since it was first rumoured a week and a half ago.
spectoacc: Undoubtedly an interesting strategy, one they're also pursuing within SBO. Basically: later funding rounds, miniscule stakes, during a bubble. Which isn't to say they won't get out again for a profit in a flotation. But they've no control over the timing. SUPP now own $13.7m of an allegedly $33bn co. A third of a thousandth of a %. ["Global neobank". No need to comment on that.] "Schroder UK Public Private Trust plc (the "Company") is pleased to announce it has made a $13.7m investment in the leading disruptive global neobank, Revolut Limited ("Revolut"). This represents the second new private equity investment since the appointment of Schroder Investment Management Ltd as the Company's Portfolio Manager and a clear demonstration of the continued progress towards rebalancing the portfolio. This investment is alongside Revolut's $800m Series E funding round led by new investors, SoftBank Vision Fund 2 and Tiger Global Management, valuing the business at $33 billion. The Company has invested on the same terms as the Series E." (For context: "Fintech startup Revolut has filed some financial results and is sharing details with the press. In 2020, the company reported $361 million in revenue (£261 million) — that's a 57% increase compared to 2019 revenue of $229 million (£166 million)"). Approx the same market cap as NatWest Group. SUPP NAV allegedly £471m, I'd question how far £10m ($13.7m) goes towards "..Rebalancing the portfolio". Says a lot more about whether the remaining stakes are worth supporting. Am sure Atom Bank would have appreciated the cash.
chucko1: Having stopped laughing, an update on the trade idea. IPO is roughly flat versus SUPP over a recent time frame, although outperformed by 50-60% over 9 months or so. The alternatives are up 10% over the recent time frame and up only about 20% over 9 months. So, were you to have tried playing ON by selling your SUPP and buying 20% of IPO and 80% the alternatives, you would be up 10-15%. But with SUPP now down at 30.85p on a NAV of 45p or so, I just don't see further value in the trade idea and would reverse it. Implicitly, that would mean buying SUPP! Except it wouldn't, as all I said was to sell it beforehand and replace it with the others were you keen to maintain some sort of exposure to ON. 15% on a portfolio with 25% exposure to ON has, I suppose, achieved a 60% return in effect on the ON portion. And as that was the point of the trade in the first place, you might declare on that score. I think SUPP is not expensive now, but who really cares? Why bother, unless you feel the discount is enticing as compared with the further revaluations that some fear. That said, I see that at near 30p, some will care a lot and (value funds, for example) and this will find higher levels again. And at this stage, I feel the alternatives are rather more exposed to unfortunate outcomes with interest rates. For SUPP, I think it will matter little.
chucko1: So another bad day for IPO and another poor day for SUPP. But one day is just noise. And yet, the alternatives are stable. What does this mean? If you are of the opinion as I am, in that IPO + alternatives are a better bet than SUPP, this has just about been born out the past 2 months. It rather depends upon the ratios you care to apply, but with exposures to ON of 5% and 25% respectively, were you to have sold 1 unit of SUPP, bought 0.2 units of IPO and 0.8 units of, say, PCT or WWH(or whatever combination of the latter pair you fancy), you would have done OK (around +4%) over the medium term. The precise profit also depends upon the day(s) of execution, but this being ADVFN, everyone will claim to have picked the best one(s). It's all about factors, and for these sorts of assets, it's not the simplest task properly identifying the principal (determining) ones at any given time. (though it was clear that the principal factor for SUPP had at one time been simply the non-numeric "Woodford").
spectoacc: The Juniors get to punt on something at last: Https://citywire.co.uk/investment-trust-insider/news/supp-unveils-schroders-first-investment-since-woodford/a1512255?ref=investment-trust-insider-latest-news-list "Fund managers Tim and Ben said: ‘We see Tessian as a great fit for the portfolio – a high quality, UK-headquartered technology business, with highly reputable co-investors, that is pioneering a disruptive new approach to cybersecurity that is scaling internationally. We couldn’t be more excited by the opportunity that lies ahead of this high-growth innovative business.’ Great, but. They've put in £4.8m. It's a $500m co. Schroders have had more than that £4.8m out of SUPP in fees since getting to the point of making this first new investment. So even if it say trebles over the next 18 months, it'll only cover the fees that Woody wasn't charging. If I was a shareholder (ho ho) I'd very much want the eventual ON cash returning, not punted on de minimus holdings. Even assuming Tim & Ben have hidden talent, how many successful punts would be needed to triple the share price back to the issue price of 2015.
chucko1: Isn't IPO 25% exposed to ON and SUPP only about 4%? I have not seen the Stocko stuff (in fact, I have not the least idea what it is), but if I am correct then you would have to buy 6.25x as much SUPP to get the same actual exposure to IPO. Whether or not SUPP is "cheap" however so defined, the risk in having to buy 6.25x as much can hardly be ignored. For it means you are buying 6.25x as much IH as a sane person would wish. And 6.25x as much Atom, with the funding requirements involved there also. Where the calculation becomes more complex is when taking into consideration the respective current valuations of ON within the portfolios of SUPP and IPO, and that is not that clear. This is where Stocko might have a better idea than me, but to use this calculation properly would require a clear view of where ON would be priced. The valuation difference would have to be immense (it is not) to offset the risk of having go buy 6.25x SUPP. Either that or you are very confident that the discount SUPP currently trades at will narrow, in which case whatever happens to ON is barely relevant if it only amounts to 4% of the NAV. I would love to be shown to be incorrect, but until someone presents the analysis here I suspect "clueless" is still apt for the majority of SUPP acolytes.
chucko1: The point about investing via IPO is that you did not expose yourself to the very likely further markdowns in the NAV of the other stuff (in SUPP). So, the idea that you get better (lower price) like-for-like exposure via SUPP is missing the point. As has been shown the past year (IPO up 200% or so and SUPP up 50% or so). They might have said precisely the same thing then. But what of the future? Closer call now but only because of the further write-down suffered by SUPP (basically another 12% taken from the share price). If they have IH valued still at anything other than nominal, then you can add to the troubles. And what of the future funding requirements? Why bother with the baggage?
spectoacc: @zimmie - a brave call to suggest more coming over the next 12 months. Yes, they've bounced from Covid lows - underperforming the FTSE - but still a bounce, & I was fortunate to sell out what I'd bought at under 30p before this week's NAV fiasco, as posted at the time. ON may float - perhaps 5p on the NAV, more if lucky. But that return isn't coming back to shareholders - it's going into new punts, they've said as much. "Schroders Juniors" because it's a pair of untested kids - now also running SBO, but still taking the same fees out of SUPP. SBO is a mess of tiny stakes, and I think they'll do the same with any SUPP cash. In which case, your "Patient" of the past 6 years extends out for how long? When do you ever expect to see a return, of any kind? What have Schroders achieved in over a year. Buying the Kymab that WEIF were dumping was a big plus. But selling a decent set of holdings at a 22% discount to Link's already marked-down NAV was poor. Now they want you to trust them to invest SUPP's ON cash. I'd be delighted to research the "..ON and other Kymab's.." you mention. I see a NAV still not kitchen-sinked, and an share price trading far too near to it, even adding 5p for ON. But good luck to holders, something may turn up?
pete_bane: I'm expecting to hear from chuckowinnie, or specto, or jonwig any minute. They check the SUPP share price every 15-20 minutes and they post to crow if it ever goes lower by .3 of a penny. Still a long way from 0p, though, which all three predicted (and topvest) LOL. I'm having a basalt fibre cake for Christmas.
Schroder Uk Public Private share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Schroder U..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210925 19:46:38